✦ LIBER ✦

Synthesis of tritium labelled 4P-PDOT, a selective melatonin receptor antagonist

✍ Scribed by Sung W. Rhee; Mary J. Tanga

Publisher: John Wiley and Sons
Year: 2000
Tongue: French
Weight: 319 KB
Volume: 43
Category: Article
ISSN: 0022-2135
DOI: 10.1002/1099-1344(200008)43:9<925::aid-jlcr378>3.0.co;2-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synthesis of the tritium labeled SCH 582

Synthesis of the tritium labeled SCH 58261, a new non-xanthine A2A adenosine receptor antagonist

✍ Pier Giovanni Baraldi; Barbara Cacciari; Silvio Dionisotti; Judith Egan; Giampie 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 375 KB 👁 1 views

The tritium labeled form of 5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo[4,3-e] 1,2,4-triazolo[l,5-c]pyrimidine (3H-SCH 58261) was obtained by reduction of 5-amino-7-[2-(2',4',5'-tribromo)phenylethyl]-2-(2-furyl)-pyrazolo[4,3-e] 1,2,4-triazolo[ 1,5clpyrimidine with tritium gas in the presence of 10

Synthesis of 14C-labelled CGS 19755, a s

Synthesis of 14C-labelled CGS 19755, a selective NMDA antagonist

✍ Alban J. Allentoff; Mahesh Desai; Bohdan Markus; Timothy Duelfer 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 462 KB

CGS 19755 is a selective NMDA (N-methyl-D-aspartate) antagonist presently under development as a neuronal protecting agent after stroke and head trauma. It was synthesized with 1%-labelling in the carboxylic acid side chain via the synthetic route displayed in Scheme 1. Key steps in the synthesis in

Super high specific activity tritium lab

Super high specific activity tritium labelled receptor ligands - I. The use of polybromodiphenylacetic acid as a tritiation substrate. Synthesis of a tritium labelled sodium-channel blocker and angiotensin II antagonist with super high specific activity

✍ Leyi Gong; Howard Parnes 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 406 KB 👁 2 views

We describe herein the synthesis of polybromodiphenylacetic acid (&), a fragment common to the tritiation substrates (a) and (JJ) of the sodium channel blocker, PD-85639 (1) and the angiotensin II inhibitor EXP-655 (2) respectively. Preparation of (a) and (11) followed by reductive debromonation wit

Synthesis of a 11C-labelled derivative o

Synthesis of a 11C-labelled derivative of the N-methyl-D-aspartate receptor antagonist MK-801

✍ Yvonne Andersson; Niklas Tyrefors; Sven Sihver; Hirotaka Onoe; Yasuyoshi Watanab 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 386 KB 👁 1 views

Synthesis of deuterium and tritium label

Synthesis of deuterium and tritium labelled (RS)-2-amino-3-(5-tert-butyl-3-hydroxy-4-isoxazolyl)-propionic acid (ATPA), a selective kainic acid receptor agonist

✍ Tommy N. Johansen; Calvin R. Hawes; Gareth J. Ellis; Bjarke Ebert; Tine B. Stens 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 315 KB 👁 2 views

Synthesis of tritium labelled (R) and (S

Synthesis of tritium labelled (R) and (S)-3-aminoquinuclidine: A ubiquitous component of serotonin receptor ligands, part II

✍ Mohammad R. Masjedizadeh; Howard Parnes 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 398 KB 👁 2 views

S)-3-Aminoquinuclidine-3H 1 Oc-S having a specific activity of 66 Ci/mrnol was prepared in eight steps from lsonicotinic acid (2). Reduction of 2 with carrier free tritium gas over PtO2 In DMF gave isonipecotic acid-3H &. Conversion to a-bromo ketone followed by cyclization afforded 3-quinuclidone-